Newsweek
Colossal Biosciences, the pioneering de-extinction company, has secured $200 million in Series C funding.
Read More
Celebrity and Billionaire Backed Company Colossal Biosciences Takes De-Extinction Mainstream
Colossal Biosciences, the pioneering de-extinction company, has secured $200 million in Series C funding.